Literature DB >> 6966063

A critical look at the accuracy of endoscopy and double-contrast radiography of the upper gastrointestinal (UGI) tract in patients with substantial UGI hemorrhage.

R F Thoeni, J P Cello.   

Abstract

Double-contrast radiography and endoscopy were compared in a prospective study of 100 patients with substantial hemorrhage of the upper gastrointestinal (UGI) tract. Endoscopy enabled detection of the primary bleeding site in 93% of the patients and correct diagnosis of 91% of all UGI lesions present. Double-contrast radiography detected 80% of primary bleeding sites and 76% of all UGI lesions present; whether the double-contrast examination was performed before or after endoscopy did not change its ability to detect lesions. Radiography demonstrated 68% (esophagitis) to 86% (duodenitis) of all superficial lesions. Endoscopy missed lesions in the duodenum and esophagus most frequently, while double-contrast radiography missed lesions in the esophagus most frequently. With the two modalities combined, the overall diagnostic accuracy for all lestions was 99%. Endoscopy and double-contrast radiography are complementary techniques for detecting acute bleeding sites of the UGI tract.

Entities:  

Mesh:

Year:  1980        PMID: 6966063     DOI: 10.1148/radiology.135.2.6966063

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging?

Authors:  V Panebianco; H Grazhdani; F Iafrate; M Petroni; M Anzidei; A Laghi; R Passariello
Journal:  Eur Radiol       Date:  2005-07-22       Impact factor: 5.315

2.  Stopping the haemorrhage from peptic ulcers.

Authors:  A E Young
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

3.  Clinical approach to diagnostic endoscopy in patients with upper gastrointestinal bleeding.

Authors:  J F Morrissey
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.